Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Opening Session Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement




Jun
18
Today In Oncology
New ACSM Expert Consensus Statement: Exercise in Children and Adolescents With Cancer
Preclinical Research Shows Interferon May Attenuate Neutrophil Response to Cancer Immunotherapy
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia
Relapsed or Refractory Multiple Myeloma Talquetamab Daratumumab
FDA Approves Capivasertib Plus Abiraterone and Prednisone for Metastatic Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo